Showing results (61-70 of 412) with videos related to
Sort By:
Pageof 42
Current Topics in Behavioral Neurosciences|June 13, 2014
Physiological correlates of positive symptoms in schizophreniaSilvana Galderisi, Annarita Vignapiano, Armida Mucci, et al.Biological Psychiatry|February 1, 2011
Mapping repetition suppression of the N100 evoked response to the human cerebral cortexNash N Boutros, Klevest Gjini, Horst Urbach, et al.Clinical EEG and Neuroscience|September 4, 2018
Evoked Potentials Investigations of Deficit Versus Nondeficit Schizophrenia: EEG-MEG Preliminary DataNash N Boutros, Klevest Gjini, Frank Wang, et al.Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 15, 2009
Standard EEG and the difficult-to-assess mental statusKanwaldeep S Sidhu, Richard Balon, Victor Ajluni, et al.Clinical EEG and Neuroscience|August 6, 2019
Deficit Versus Nondeficit Schizophrenia: An MEG-EEG Investigation of Resting State and Source Coherence-Preliminary DataKlevest Gjini, Susan M Bowyer, Frank Wang, et al.Psychiatry Research|June 1, 1993
The P50 component of the auditory evoked potential and subtypes of schizophreniaN Boutros, G Zouridakis, T Rustin, et al.Pharmacological Research|January 1, 1992
Membrane antiperoxidative activities of D-propranolol, L-propranolol and dimethyl quaternary propranolol (UM-272)I T Mak, W B WeglickiMolecular and Cellular Biochemistry|December 16, 1992
Antioxidant drug mechanisms: transition metal-binding and vasodilationW B Weglicki, I T MakJournal of Biomaterials Applications|December 23, 2004
Hydraulic permeability of polyglycolic acid scaffolds as a function of biomaterial degradationJiashen Li, Arthur F T MakCirculation Research|May 1, 1990
Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidationI T Mak, W B WeglickiPageof 42